AG Phar SRL
2.0 FTEAG Phar reported total assets of 638,057 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Aug 2026), with 2 full-time equivalents.
The score of AG Phar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +98 % Total assets -2 % Headcount (avg FTE) +122 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AG Phar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 26 Apr 2024
AG Phar's financial analysis
- Solvency18.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AG Phar
AG Phar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0794.921.433
- VAT number
- BE0794921433
- Peppol
- Registered · 0208:0794921433 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2022
- Registered office
- 4000 Liège
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AG Phar (SRL) has been based in Liège since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 34,415 € and equity of 117,428 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.4%, below the median of its sector (41.5%).
Companies similar to AG Phar
Companies in the same business, of comparable size and area, outside its group.
- API Pharma Retail sale of pharmaceutical products Liège · balance sheet 116,460 €
- Devillé - Boeykens Retail sale of pharmaceutical products Londerzeel · balance sheet 631,150 €
- Gelaphar Retail sale of pharmaceutical products Voeren · balance sheet 774,089 €
- Farmacie Henri Retail sale of pharmaceutical products Edegem · balance sheet 635,645 €
- Apotheek ANN Verplaetse Retail sale of pharmaceutical products Kuurne · balance sheet 683,926 €
- Pharmacie De Buijl Retail sale of pharmaceutical products Rebecq · balance sheet 709,736 €
- Amygephar Retail sale of pharmaceutical products Neupré · balance sheet 717,127 €
- Libo Consult Retail sale of pharmaceutical products Halen · balance sheet 516,567 €
Frequently asked questions about AG Phar
What is the revenue of AG Phar?
AG Phar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AG Phar?
In Belgium, the VAT number is the company number prefixed with BE: BE0794921433 for AG Phar, if the company is VAT-registered. Its company number (CBE) is 0794.921.433.
Where is the registered office of AG Phar?
According to the CBE register, the registered office of AG Phar is in 4000 Liège.
What is the equity of AG Phar?
At the close of the 2025 financial year, the equity of AG Phar amounts to 117,428 €, a solvency of 18.4% of total assets.
How many people work at AG Phar?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages AG Phar?
The register lists 2 active mandates at AG Phar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AG Phar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →